Technetium [99mTc]-H7ND in Patients With Gastrointestinal Malignancies and Healthy Volunteers

NCT06443710 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Technetium [99mTc]-H7ND injection

Sponsor

Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd.